Technische Universität Dortmund Fakultät für Chemie und Chemische Biologie Dortmund, Germany
Dr. Stephen Pelly
Researcher, Department of Chemistry Emory University, Atlanta, USA
Additional Collaborations
Industrial Collaborations
2000 (January – April), Hanessian Laboratories, University of Montreal, Canada – AstraZeneca, Gothenburg, Sweden Research Project. 2-Piperidone Library (Series 4): Synthesis of 80 compound library for biological screening by W.A.L. van Otterlo and M. Seid.
2001 (January – May), Hanessian Laboratories, University of Montreal, Canada – AstraZeneca, Gothenburg, Sweden Research Project. Synthesis of Aromatic P2 Scaffolds as Potential Thrombin Inhibitors for biological screening by W.A.L. van Otterlo and M. Bayrakdarian.
2007 (until present), CSIR, Modderfontein. Medicinal Chemistry Projects): Variety of collaborations with the CSIR involving anti-malarial projects, C.B. de Koning, W.A.L. van Otterlo, A. Rousseau, S. Pelly and E. M. Mmutlane.
2010 (until present), NECSA, Broederstroom, Pretoria. Medicinal Chemistry and Fluorine Beneficiation Projects): Variety of collaborations with the NECSA involving the incorporation of 18F into bioactive compounds and the incorporation of fluorine into aromatic compounds, D. van der Westhuizen, C. Wagener, J.-R. Zeevaart, W.A.L. van Otterlo, T.S. Sello and E.L. Ngidi.
Collaborations with other South African Universities
2006 (until present), Research Niche Area (RNA). Synthesis and in vitro screening of potentially bioactive compounds: Main areas of collaboration: Anti-cancer testing with Dr H. Davids (School of Pharmacy and Pharmacology), anti-microbial testing with Mrs S van Vuuren (School of Pharmacy and Pharmacology), anti-malarial testing with Drs RL van Zyl and L Harmse (School of Pharmacy and Pharmacology).
2007 (until present), Non-viral gene transfer agents: Main areas of collaboration: Design, synthesis and testing of cholesterol-based compounds as transfection agents with Prof P Arbuthnot of the Antiviral Gene Therapy Research Unit at the Department of Molecular Medicine and Haematology, University of the Witwatersrand.